64 research outputs found
Shmt2: a stat3 signaling new player in prostate cancer energy metabolism
Prostate cancer (PCa) is a multifactorial disease characterized by the aberrant activity of different regulatory pathways. STAT3 protein mediates some of these pathways and its activation is implicated in the modulation of several metabolic enzymes. A bioinformatic analysis indicated a STAT3 binding site in the upstream region of SHMT2 gene. We demonstrated that in LNCaP, PCa cells' SHMT2 expression is upregulated by the JAK2/STAT3 canonical pathway upon IL-6 stimulation. Activation of SHTM2 leads to a decrease in serine levels, pushing PKM2 towards the nuclear compartment where it can activate STAT3 in a non-canonical fashion that in turn promotes a transient shift toward anaerobic metabolism. These results were also confirmed on FFPE prostate tissue sections at different Gleason scores. STAT3/SHMT2/PKM2 loop in LNCaP cells can modulate a metabolic shift in response to inflammation at early stages of cancer progression, whereas a non-canonical STAT3 activation involving the STAT3/HIF-1α/PKM2 loop is responsible for the maintenance of Warburg effect distinctive of more aggressive PCa cells. Chronic inflammation might thus prime the transition of PCa cells towards more advanced stages, and SHMT2 could represent a missing factor to further understand the molecular mechanisms responsible for the transition of prostate cancer towards a more aggressive phenotyp
Incidental prostatic stromal tumor of uncertain malignant potential (STUMP): histopathological and immunohistochemical findings
Stromal prostate tumors are rare neoplastic proliferative lesions that have been classified into prostatic
stromal tumor of uncertain malignant potential (STUMP) and prostatic stromal sarcoma (SS) based
on these criteria: stromal cellularity, presence of mitotic figures, necrosis, and stromal overgrowth. A
prostatic stromal tumor of uncertain malignant potential (STUMP) is a non-epithelial, mesenchymal
spindle-cell tumor that can be classified as a specialized stromal tumor of the prostate. STUMPs have
the capability to diffusely infiltrate the prostate gland and extend into adjacent tissues. Furthermore,
they often recur and this is why they are considered as neoplastic entities. STUMPs usually tend to be
not aggressive, but occasional cases have been reported with an extension into adjacent tissues. A
few cases develop a sarcomatous dedifferentiation.
A 67-year-old male referred to the Department of Urology, Sapienza Rome University, with acute urinary
retention (AUR) and bladder overdistention. Digital rectal examination (DRE) showed the presence
of a severe prostatic hyperplasia and a transvesical prostatic adenomectomy (TVPA) was performed.
The pathological evaluation performed at the Department of Pathology, Sapienza Rome University,
revealed an incidental diagnosis of prostatic STUMP. The patient’s follow-up is made every year with
transrectal ultrasonography and nuclear magnetic resonance with spectroscopy, and every two years
with a transperineal prostate biopsy to exclude a progression to a stromal sarcoma. After 5 years of
follow-up the STUMP is still detectable but there is no sign of sarcoma. As a result of its relative rarity
and lack of long-term follow-up, the prognosis of STUMP is unclear. Therapy varies from a wait-andsee
approach to a radical retropubic prostatectomy
Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy
Purpose To evaluate the diagnostic accuracy of SelectMDx and its association with multiparametric magnetic resonance
(mpMRI) in predicting prostate cancer (PCa) and clinically significant PCa (csPCa) on prostate biopsies among men scheduled
for initial prostate biopsy.
Methods In this single-center prospective study, 52 men scheduled for initial prostate biopsy, based on elevated total PSA
level (> 3 ng/ml) or abnormal digital rectal examination, were consecutively included. All subjects underwent SelectMDx,
PSA determination and mpMRI.
Results SelectMDx score was positive in 94.1 and 100% of PCa and csPCa, respectively, and in only 8.6% of negative cases
at biopsy. The probability for a csPCa at the SelectMDx score was significantly (p = 0.002) higher in csPCa (median value
52.0%) than in all PCa (median value 30.0%). SelectMDx showed slightly lower sensitivity (94.1 versus 100.0%) but higher
specificity (91.4%) than total PSA (17.1%), and the same sensitivity but higher specificity than mpMRI (80.0%) in predicting
PCa at biopsy. The association of SelectMDx plus mpMRI rather than PSA density (PSAD) plus mpMRI showed higher specificity
(both 91.4%) compared to the association of PSA plus mpMRI (85.7%). In terms of csPCa predictive value, SelectMDx
showed higher specificity (73.3%) than PSA (13.3%) and mpMRI (64.4%); as for the association of SelectMDx plus mpMRI
(75.6%) versus PSA plus mpMRI (68.9%), the association of PSAD plus mpMRI showed the highest specificity (80.0%).
Conclusion Our results of SelectMDx can be confirmed as significant but their impact on clinical practice together with a
cost-effectiveness evaluation should be investigated in a larger prospective multicenter analysis
Cribriform pattern does not have a significant impact in Gleason Score ≥7/ISUP Grade ≥2 prostate cancers submitted to radical prostatectomy
The aim of this study was to correlate cribriform pattern (CP) with other parameters in a large prospective series of Gleason score ≥7/ISUP grade ≥2 prostate cancer (PC) cases undergoing radical prostatectomy (RP)
Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy
Background: Aim of this study was to correlate perineural invasion (PNI) with other clinical-pathological parameters in terms of prognostic indicators in prostate cancer (PC) cases at the time of radical prostatectomy (RP).
Methods: Prospective study of 288 consecutive PC cases undergoing RP. PNI determination was performed either in biopsy or in RP specimens classifying as uni- and multifocal PNI. The median follow-up time was 22 (range, 6-36) months.
Results: At biopsy PNI was found in 34 (11.8%) cases and in 202 (70.1%) cases at the time of surgery. Among those identified at RP 133 (46.1%) and 69 (23.9%) cases had uni- and multi-PNI, respectively. Presence of PNI was significantly (P<0.05) correlated with unfavorable pathological parameters such higher stage and grade. The percentage of extracapsular extension in PNI negative RP specimens was 18.6% vs. 60.4% of PNI positive specimens. However, the distribution of pathological staging and International Society of Urological Pathology (ISUP) grading did not vary according to whether PNI was uni- or multifocal. The risk of biochemical progression increased 2.3 times in PNI positive cases was significantly associated with the risk of biochemical progression (r=0.136; P=0.04). However, at multivariate analysis PNI was not significantly associated with biochemical progression [hazard ratio (HR): 1.87, 95% confidence interval (CI): 0.68-3.12; P=0.089]. Within patients with intermediate risk disease, multifocal PNI was able to predict cases with lower mean time to biochemical and progression free survival (chi-square 5.95; P=0.04).
Conclusions: PNI at biopsy is not a good predictor of the PNI incidence at the time of RP. PNI detection in surgical specimens may help stratify intermediate risk cases for the risk of biochemical progression
An embarrassed patient was unmasked by the endoscopic diagnosis. A case of Enterobius vermicularis infection in Italy.
Super-slim endoscopy, in a patient with a Crohn’s ileocecal valve stricture, for assessment of mucosal healing
Crohn’s disease (CD) is an inflammatory bowel (IBD) disease involving any segment of the gastrointestinal tract.
Colonoscopy, in association with terminal ileum visualization and biopsies, is the gold standard for a correct
endoscopic surveillance in CD patients [1]. Direct disease activity monitoring and histological grading represent the
main advantage of endoscopy [2], helping physicians to optimize treatment. Ten to twenty-five percent of CD
patients present with at least one small bowel or colonic stricture, which often prevents complete endoscopic
examination. Thus, when standard endoscopes are unable to proceed beyond colonic or ileal strictures, more
sophisticated and costly imaging techniques, such as entero-computed tomography (CT) or magnetic resonance
imaging (MRI), are used. However, they do not allow histological evaluation or therapeutic procedures. The use
of ultrathin endoscopy (UE) has been proposed in the case of narrow bowel angulations [3] and stricturing colonic
lesions, in patients with ulcerative colitis [4] and CD [5, 6].
We describe the successful use of a super-slim, two-way angulation, endoscope (outer diameter 4.9 mm) to explore
the terminal ileum in a patient with severe ileocecal valve strictures due to CD. The technique allowed us to successfully
complete the examination of the terminal ileum, obtain biopsies, and optimize the treatment strategy
- …